Breaking News
5386 - 5400 of 6609 results
Prev
358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441
Next
August 21, 2007
MPI Research has appointed David Serota, Ph.D., DABT to the position of vice president, toxicology and pathology, as well as a member of the company's senior management team, and Tina Rogers, Ph.D., DABT joined the company as the associate director o…
Read More »
August 21, 2007
Abraxis BioScience, Inc. and The Scripps Research Institute (TRSI) have entered an exclusive licensing agreement for the worldwide development and commercialization of an epothilone therapeutic for the treatment of cancer. Epothilones are a new class…
Read More »
August 20, 2007
Enzon Pharmaceuticals, Inc. is selling 25% interest in its royalty from PEG-INTRON, marketed by Schering-Plough Corp. for $92.5 million to Drug Royalty Corp., Inc. (DRC). Enzon is also eligible to receive an additional one-time milestone payment of $…
Read More »
August 20, 2007
Alphora Research, Inc. has invested in a new pilot plant facility in an effort to increase its range of services. The company recently expanded to include a 14,000-sq.-ft. facility. The cGMP pilot plant is currently under construction and is expected…
Read More »
August 17, 2007
Nexgen Pharma, Inc. has acquired certain assets of The Chemins Company, Inc. located in Colorado Springs, CO. The acquisition includes 250,000 sq. ft. of manufacturing, laboratory and warehouse/distribution space.
Gary Korngold, Nexgen's execut…
Read More »
August 17, 2007
ARTEC, Inc. has made key appointments with the goal of initiating the production and global distribution of Tubercin and related immunostimulant medicines.
"R&D of Tubercin is complete, requiring no further refinement or alteration in t…
Read More »
August 17, 2007
Schwarz Pharma, a subsidiary of UCB, submitted a MAA to the EMEA for Vimpat to treat diabetic neuropathic pain and it has been accepted for review.
Vimpat is an anticonvulsant drug with a novel dual mode of action acting on CRMP-2 (collapsing…
Read More »
August 16, 2007
Amgen plans to reduce its headcount by 12-14% or 2,200-2,600 staff in an effort to "create operational efficiencies" and support R&D investments. These initiatives, expected to yield savings of between $1 billion - $1.3 billion in 2008,…
Read More »
August 16, 2007
Cell Therapeutics, Inc. will acquire Zevalin, the first FDA-approved radioimmunotherapy, from Biogen Idec. CTI will be responsible for marketing, sales, and development of the drug in the U.S. The drug will continue to be sold outside the U.S. by Bay…
Read More »
August 16, 2007
Pharmatek Laboratories, Inc. has added cytotoxic and high-potent drug development capabilities to its pharmaceutical chemistry development services. These services include: analytical method development, preformulation testing, formulation developmen…
Read More »
August 15, 2007
Millipore Corp. expanded its agreement with Novo Nordisk to provide recombinant human insulin, a key cell culture supplement used to manufacture biologic drugs.
Under the terms of the agreement, Millipore will have exclusive worldwide rights to…
Read More »
August 15, 2007
Michael Troullis has been named chief financial officer, Quintiles Transnational Corp., effective immediately. Mr. Troullis had been acting chief financial officer for the past year. He will report to Dennis Gillings, CBE, chairman and chief executiv…
Read More »
August 15, 2007
The FDA has accepted for review GlaxoSmithKline's BLA for Rotarix, an oral candidate vaccine for infants to prevent rotavirus gastroenteritis. If approved, the GSK candidate vaccine could offer completion of the rotavirus vaccination series by four m…
Read More »
August 15, 2007
Sancilio & Company, Inc. is expanding the analytical services offered through its FDA and DEA registered cGMP analytical chemistry lab at SCI's Riviera Beach, FL location.
Dr. Nealie Newberger, formerly of the Analytical Services Lab at SCI,…
Read More »
August 14, 2007
Icagen, Inc. has entered into a worldwide collaboration and licensing agreement with Pfizer for the discovery, development and commercialization of ion channel-focused therapeutics for pain and related disorders. The two companies will combine resour…
Read More »
5386 - 5400 of 6609 results
Prev
358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441
Next
